Skip to main content

Building

A better future

through education, skill development and research

LEARN MORE

Pressroom

Latest News

  • Lupus Treatment Generates Positive Results in Phase III Clinical Trial

    April 20, 2018

    New research indicates that belimumab, a monoclonal antibody therapy that targets a component of the immune system, provides considerable benefits to patients with systemic lupus erythematosus (SLE), a predominately female, chronic inflammatory disease that can affect virtually any organ.

Corporate News RSS

Business Wire NewsHQsm